BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 14599092)

  • 1. Epidemiology and clinical burden of acute myeloid leukemia.
    Redaelli A; Lee JM; Stephens JM; Pashos CL
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):695-710. PubMed ID: 14599092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging strategies for the management of acute myeloid leukemia in the elderly.
    Laubach J; Rao AV
    Oncologist; 2008 Oct; 13(10):1097-108. PubMed ID: 18922830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myelogenous leukemia.
    Shipley JL; Butera JN
    Exp Hematol; 2009 Jun; 37(6):649-58. PubMed ID: 19463767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute myeloid leukemia in older patients.
    Roboz GJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):285-95. PubMed ID: 17338649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia.
    Ferrara F; Palmieri S; Mele G
    Haematologica; 2004 Aug; 89(8):998-1008. PubMed ID: 15339685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of childhood acute myeloid leukemia.
    ter Bals E; Kaspers GJ
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia.
    Litzow MR
    Curr Opin Hematol; 2007 Mar; 14(2):130-7. PubMed ID: 17255790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia: epidemiology and etiology.
    Deschler B; Lübbert M
    Cancer; 2006 Nov; 107(9):2099-107. PubMed ID: 17019734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy.
    Tiesmeier J; Müller-Tidow C; Westermann A; Czwalinna A; Hoffmann M; Krauter J; Heil G; Ganser A; Serve H; Verbeek W
    Leuk Res; 2004 Oct; 28(10):1069-74. PubMed ID: 15289019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party.
    Ferrara F; Fazi P; Venditti A; Pagano L; Amadori S; Mandelli F
    Hematol Oncol; 2008 Jun; 26(2):104-7. PubMed ID: 18271064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapeutic strategies for acute myeloid leukaemia.
    Kolitz JE
    Br J Haematol; 2006 Sep; 134(6):555-72. PubMed ID: 16848792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New agents for the treatment of acute myeloid leukemia.
    Tallman MS
    Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of childhood acute myeloid leukemia.
    Behm FG
    Clin Lab Med; 1999 Mar; 19(1):187-237, vii. PubMed ID: 10403081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.
    Kaspers GJ; Zwaan CM
    Haematologica; 2007 Nov; 92(11):1519-32. PubMed ID: 18024401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
    Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies other than dose-intensification should be pursued in elderly patients with untreated acute myeloblastic leukemia.
    Haematologica; 2002 Aug; 87(8):786. PubMed ID: 12161350
    [No Abstract]   [Full Text] [Related]  

  • 19. Biology and management of relapsed acute myeloid leukaemia.
    Craddock C; Tauro S; Moss P; Grimwade D
    Br J Haematol; 2005 Apr; 129(1):18-34. PubMed ID: 15801952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.
    Kuendgen A; Germing U
    Cancer Treat Rev; 2009 Apr; 35(2):97-120. PubMed ID: 18951721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.